INTRODUCTION
In the process of designing new drug molecules, permeation of drugs through the Blood Brain Barrier (BBB) is elementary for the antipsychotics to interact with the specific site of action inside the Central nervous system (CNS). The BBB is composed of distinctly specialised microvascular endothelial cells along with astrocytes, neurons, pericytes, microglia and basement membrane 1, 2 . The endothelial capillary cells are interconnected by claudins, occludins (proteins) and adhesion molecules resulting in tight junctions, which shut the intercellular space, thus limiting the permeability of many CNS active molecules 3, 4 However large number of molecules can enter the Central nervous system(CNS) through transcellular passive diffusion, resulting due to concentration gradient between brain and blood 5 . Off the available drugs, only 2% are able to cross the BBB especially antipsychotics. Drugs due to their physiological and molecular properties, polar surface area, hydrophilicity, hydrophilicity, molecular charge and size can easily cross the BBB, hence BBB permeability for the prospective drug molecules at different conditions would be of paramount importance in the design and development of these molecules as drugs 6 . In the present study we are assessing the Blood Brain Barrier (BBB) permeability potentials of 6-fluoro-3-(piperidin-4-
isoxazole-3-yl) piperidine-1-carbothiamide (S4) along with the standard antipsychotic drugs Haloperidol and Resperidone , through in vitro and in silico methods. All the above molecules in our earlier studies have satisfied Lipinski`s rule of five parameters suggesting that they are orally bioavailable, non-toxicity, and indicated significant bioactive scores, thus making them suitable candidates for further investigation as potential Antipsychotic drugs, in this regard BBB permeability studies is an very important and essential criteria for the molecules to qualify for further antipsychotic studies. Hence in vitro screening of the molecules was conducted using Parallel artificial membrane permeability assay (PAMPA) in PBS and in silico screening was done using rodent model.
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ABSTRACT
Blood Brian Barrier (BBB) is a physiologically and metabolically significant membrane that enables and limits the uptake of specific molecules by the brain, thus preserving the homeostasis within the Central nervous System (CNS).All the Antipsychotic drugs are permeable across the BBB, however most of First/Second generation antipsychotic drugs employed in the medical field are known to be associated with Extrapyramidal symptoms (EPS). Hence our interest is devoted in the development of novel antipsychotic drugs that ameliorate psychosis with least frequency of EPS. In our previous study the newly synthesized molecules, 6-fluoro-3-(piperidin-4-yl) benzo[d]isoxazole derivatives (S1-S4) which have shown positive alterations in chemical properties and biological activities demonstrating significant neuroleptic properties. However possibility and efficiency of these synthesized molecules to penetrate through the Blood Brain Barrier will be of utmost importance to determine its treatment efficacy. In this line of investigation, in the present study, in silico and in vitro methods are employed to evaluate the permeability in comparison with that of standard antipsychotic drugs, Resperidone and Haloperidol. In vitro analysis was done by Parallel artificial Membrane Permeability Assay (PAMPA) in PBS, where in permeability of S2(8.3x10 -6 ) and S3(6.6x10 -6 ) molecules showed higher permeability than known standards Warfarin(1x10 -6 ), Resperidone(2.3x10 -6 ) and Haloperidol(3.5x10 -6 ), and the molecules exhibited recovery above 50% and in silico studies also showed high permeability rate with all the synthesized molecules. Thus we can conclude that, all the synthesized molecules have the potential to develop into promising Antipsychotic drugs.
MATERIAL AND METHODS

Materials
All the chemicals were procured form Fluka, Merck and Sigma Aldrich. Permeability assay was performed in Phosphate buffer (PBS, K 2 HPO 4 and KH 2 PO 4 , pH 7) in Multiscreen Millipore TM, plate and PTFE acceptor plate. L-α-Phosphatidylcholine, and Dimethyl Sulfoxide was purchased from (Sigma,USA) and Dodecane was purchased from (Fluka,India) The entire reagents used in the investigation were of analytical grade. The drug analysis was done on LC-MS/MS (AB Sciex Triple Quad 5500).
Methods
PAMPA Assay:
The experiment was performed in a 96 well sandwich plate, according to Schmidt and Lynch 8 with slight modifications. 1% lecithin solution (w/v) was prepared in dodecane (~500 µL/plate) and the mixture was sonicated to ensure complete dissolution. Then 5 µL of Lecithin/dodecane mixture was carefully spiked into each donor plate well with the help of a 10 µL adjustable-volume pipette, avoiding pipette tip contact with the membrane. Immediately after the application of the artificial membrane (within 10 min maximum), 150 µL of 50 µM drug containing donor solutions (drug dissolved in PBS) was added to each well of the donor plate. 300 µL of aqueous buffer was added to each well of the acceptor plate. Slowly and carefully the drug filled donor plate was placed into the acceptor, making sure that the underside of the membrane is in contact with the buffer in all wells. Finally the lid was replaced and incubated at room temperature for 16h.The samples were than analysed on LC-MS/MS (AB Sciex Triple Quad 5500) with gradient elution mobile phase (Acetinitril:0.2% Formic acid in water) with a flow of 0.85mL/min, 2 µL wer injected with a total run time of 4.5 min using the column Atlantis C 18 (50 x 4.6 mm, 3 µm-Waters, Ireland).
Permeability calculations:
The apparent permeability Co-efficient (P app ) for the Uni-transport direction (A to B) was calculated [9] according to the following equation: ) and C D is the average drug concentration in the donor chamber over the period (∆Q~∆t) was determined.
Recovery during the experiment was calculated as:
Where (QD end + QR end ) is the final amount of the compound found in both donor and receiver sides and QD 0min is the amount in the donor side at start (0 min).
Computational studies: All computational studies were carried in the ACD/ILAB property predictions. BBB parameters such as Rate of Brain penetration (logPS), Extent of Brain penetration (logPB), Brain Plasma equilibrium constant (log PS * fu, brain) and LogBB were measured in silico.
RESULTS AND DISCUSSION
In the present study Apparent permeability (P app ) and Recovery % of the synthesized 6-fluoro-3-(piperidin-4-yl) benzo[d]isoxazole derivatives (S1-S4), Standards Warfarin, Propranolol HCl and standard Antipsychotic drugs Haloperidol and Resperidone were determined by PAMPA studies. The Apparent permeability (P app ) values for any molecule to be considered permeable across BBB will be compared to following criteria :< 1 x 10 -6 cm/sec indicates low permeability; 1 to 3 x 10 -6 cm/sec indicates medium permeability and > 3 x 10 -6 cm/sec indicates high permeability. In Table 1 , P app values of the molecules are recorded and the S2 and S3 molecules showed high permeability with 8.3 x 10 -6 cm/sec and 6.6 x 10 -6 cm/sec respectively which is found to be much higher than normally used standard compounds Propranolol HCl (3.6 x 10 -6 cm/sec) and Warfarin (1 x 10 -6 cm/sec). The values obtained for S2 and S3 is also significant as they also exhibited P app values much higher than antipsychotic drugs Haloperidol (3.2 x 10 -6 cm/sec) and resperidone (4.4 x 10 -6 cm/sec). However P app values of S1 (1.4 x 10 -6 cm/sec) and S4 (0.8 x 10 -6 cm/sec) were medium and low. The percentage of the administered drug that is actually penetrating the Blood Brain Barrier (BBB) 10 is another important factor when considering the interaction potentials of Antipsychotics within the Central nervous system (CNS) is. Thus recovery % across the membrane, of the above molecules assumes a significant factor. From the above table it is clear that the synthesized molecules S2 (79%) and S3 (77%) almost have very similar values that of Haloperidol (72%) and Resperidone (81%), predicting the positive intactness of the molecules. Even S1 (65%) and S4 (59%) showed almost similar values like that of standard Warfarin (62%). The above results clearly indicated that the synthesized molecules have very good permeability like that of the established antipsychotic drugs and standard compounds.
In silico permeability predictions: The information given in the Table 2 provides a comprehensive assessment of the permeation potential of candidate molecules based on their passive transport across the BBB. From the above 
